Tampilkan postingan dengan label 2. Mesothelioma Pain Treatment. Tampilkan semua postingan
Tampilkan postingan dengan label 2. Mesothelioma Pain Treatment. Tampilkan semua postingan

Kamis, 22 Oktober 2009

Dealing with Mesothelioma Pain

Mesothelioma pain may be chronic and acute. With the progress in cancer studies, many latest methods for controlling and treatment are growing, which don't have bad side effects on mesothelioma sufferers.
  • A little typical treatments like neurosurgery are conducted by blocking off or altering the nerve tracts through which pain transmits.
  • Nerve blockage or epidural help mesothelioma sufferers deal with pain.
  • Counseling, body therapy or meditation reduce psychological trauma of pain.
In relation to traditional mesothelioma treatment alternatives, locating the location of your cancer, the phase of the sickness and age and overall health of a patient is reasoned.

  • Typical treatments like radiation and chemotherapy also surgery are performed for the patient.
  • Radical treatment alternatives and studies has contributed to many available options. Determined by the nature and seriousness of the disease, medications like gene treatment, immune augmentative treatment, photo dynamic treatment, interferon and interleukin treatment, radio frequency ablation, and angiogenesis treatments are employed.
  • Occasionally, aggressive treatments are not conceivable due to old age and health situations. Under these circumstances, palliative therapy is suggested which handles the symptoms and not the cancer.

Minggu, 11 Januari 2009

Chemotherapy for Mesothelioma Pain


Chemotherapy involves the use of anticancer drugs that act by preventing cancer cells from multiplying. In most cases, combinations of drugs are used to increase efficiency. Chemotherapy can be used aggressively to reduce the tumor, or palliative to relieve symptoms like shortness of breath or pain. Chemotherapy can be administered by injection into a vein or muscle, or by ingestion may be administered directly into the pleural or peritoneal cavity. The drugs most commonly used are:

* Pemetrexed (Alimta)
* Cisplatin (Platinol)
* Carboplatin (Paraplatin)
* Gemcitabine (Gemzar)
* Doxorubicin (Adriamycin)
Mitomycin *
* Raltitrexed (Tomudex)
* Vinorelbine (Navelbine)

New drugs are constantly being studied by pharmaceutical companies, so do not hesitate to check with your doctor about drugs most recent and most promising. Such a drug, Alimta (pemetrexed) was approved for Europe in September 2005.
Radiotherapy

Radiotherapy involves the use of X-ray high energy to kill cancer cells and reduce tumors. It can be used in conjunction with surgery to help remove aggressively seeding microscopic which may cause the recurrence of disease, or palliative treat pain caused by tumors that compress the nerve endings or another organ. Radiation therapy was also effective in preventing tumor seeding from biopsy sites or tube drainage of the chest.
Clinical trials

The goal of clinical trials is to involve patients in the discovery of new and better treatments for their illnesses. Several clinical trials have different objectives which may include testing of new drugs, by comparing several ways to treat a disease or test several techniques to prevent cancer. Clinical trials are divided into three phases. Short summaries of what each phase of the test seeks to achieve are described below.

The Phase I trials are the earliest phase in the system of clinical trials. At this point, the drugs were only tested in the laboratory, but had a destructive effect on cancer cells. These tests n'enrĂ´lent a limited number of participants, and are only available in few institutions of cancer. The objective of Phase I trials are to determine the maximum tolerated dose of the drug without causing side effects serious side effects which are most common, and if the drug continues to have anticancer activity when administered to human beings . If the drug showed an effect on cancer at a safe dosage, the drug will be tested in Phase II trials.

The essays Phase II continue to test the safety of medications or procedures, but also begin to more carefully analyze their effectiveness for certain types of cancer. These tests include larger numbers of participants, and can be dispersed over several institutions. These tests may be "randomized", which means that different groups of participants are chosen by computer, rather than by a doctor.

The Phase III trials compare new drugs or procedures promising current standard treatment. Large numbers of participants from widely scattered regions involved in these tests, and receive either the new treatment is the standard treatment. One of the primary objectives of Phase III trials is to determine if the cancer is reduced or slowed by drugs, how long patients remain stable without progression of the disease and how treatment with the drug affects the quality of life of the patient.

If you are interested to participate in a clinical trial for mesothelioma pain, your doctor should be able to provide information on eligibility and availability in your area.

Surgery Treatment for Mesothelioma Pain

There are two surgical approaches of mesothelioma pain, the pleurectomie / decortication (P / D) and pleuropneumonectomie extrapleural (PPEP). These are highly specialized surgery, which may not be offered in all schools. All thoracic surgeons are not responsible for these types of surgeries. The ultimate objective of these procedures is the elimination of a large part of the disease, knowing that most probably the residual microscopic disease remains. Adjuvant therapy in which additional forms of treatment are used in conjunction with the primary therapy, typically aims to eliminate residual disease. The most common forms of therapy are adjuvant radiotherapy and / or chemotherapy.

The pleurectomie / decortication is considered the least radical of the two approaches since it involves only the removal of the pleura (lining of the lung) without removing the lung cover. In some cases, the pericardium and diaphragm must be removed, depending on the size of the tumor. The benefits of this procedure is a time for more rapid recovery, and utility for patients who may not be able to tolerate a more radical PPEP. The disadvantages include an increased risk of recurrence of disease because of the impossibility to remove the tumor, and the inability to use high doses of radiation adjuvants because of potential damage to the underlying lung.

The extrapleural pleuropneumonectomie is a more radical procedure which involves the removal of the lung, pleura (lining of the lung), the pericardium surrounding the heart and part of the diaphragm. During surgery, the pericardium and diaphragm are reconstructed with a material similar to Gortex. To be eligible for this surgery, patients must meet certain criteria and demonstrate stage lung function and cardiac suitable to be able to withstand the procedure.